Introduction to Selecting A Molecular Panel In Nsclc
If you are looking for information about Selecting A Molecular Panel In Nsclc, you have come to the right place. Jared Weiss, MD; Gregory J. Riely, MD, PhD; and Greg Riedlinger, MD, PhD, provide their perspectives on
Selecting A Molecular Panel In Nsclc Comprehensive Overview
In this segment, the panelists discuss Recommendations for testing patients with non–small cell Ignacio I. Wistuba, MD, Department of Translational
Jared Weiss, MD; Gregory J. Riely, MD, PhD; and Greg Riedlinger, MD, PhD, reflect on recent advances in
Summary & Highlights for Selecting A Molecular Panel In Nsclc
- Dr's. H. Jack West, Millie Das and Matthew Gubens sat down to discuss treatment options for Stage 3
- For more resources and information regarding anticancer targeted therapies: http://targetedonc.com/
- Pilar Garrido Lopez, MD, PhD, University Hospital Ramón y Cajal, Madrid, Spain, comments on the value of
- David R. Gandara, MD, Director, Thoracic Oncology Program, University of California, Davis Comprehensive Cancer Center, ...
- Panelists Suresh S. Ramalingam, MD; Marina Garassino, MD; Benjamin Besse, MD, PhD; and Giorgio Scagliotti, MD, PhD, ...
We hope this detailed breakdown of Selecting A Molecular Panel In Nsclc was helpful.